Anticancer effects of acteoside: Mechanistic insights and therapeutic status

Rasel Ahmed Khan1, Rajib Hossain2, Pranta Roy3

  • 1Pharmacy Discipline, Khulna University, Khulna, 9280, Bangladesh.

Insights

Acteoside, a natural compound, shows significant anticancer properties by impacting cancer cell proliferation, metastasis, and signaling pathways. Further clinical studies are warranted to explore its therapeutic potential in cancer treatment.

Area of Science:

  • Pharmacology
  • Natural Product Chemistry
  • Oncology

Background:

  • Cancer remains a critical global health challenge, necessitating novel therapeutic strategies.
  • Natural compounds are increasingly investigated for their potential in cancer treatment.
  • Acteoside, a phenylethanoid glycoside, possesses diverse biological activities.

Purpose of the Study:

  • To review and synthesize existing literature on the anticancer properties of acteoside.
  • To analyze the mechanisms by which acteoside exerts its anti-cancer effects.
  • To evaluate acteoside's potential as a candidate for cancer therapy.

Main Methods:

  • Comprehensive literature search using major scientific databases (PubMed, Scopus, Web of Science, etc.).
  • Analysis and summarization of studies investigating acteoside's effects on various cancer models.
  • Identification of key molecular pathways modulated by acteoside.

Main Results:

  • Acteoside demonstrates anticancer activity across multiple experimental cancer models.
  • Mechanisms include induction of oxidative stress, apoptosis, and inhibition of angiogenesis, invasion, and metastasis.
  • Acteoside exhibits anti-proliferative effects through modulation of cancer signaling pathways.
  • Synergistic effects with other anti-cancer agents have been observed.

Conclusions:

  • Acteoside displays potent anticancer activity against diverse cancer cell lines.
  • Its efficacy is mediated by the modulation of critical cancer signaling pathways.
  • Acteoside represents a promising candidate for further preclinical and clinical investigation in cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K